Cathy Gwin
Senior Director, Communications
NTI Co-Chair and CEO work urgently to reduce biological risks associated with advances in technology.
Advancements in commercially available DNA synthesis technologies pose growing risks, with the potential to cause catastrophic biosecurity threats if misused.
NTI | bio hosted two events designed to discuss steps to fill global gaps in capability to prevent biological events and to reduce biological risks.
The winning team was selected from papers submitted by students and young professionals from nine countries across four continents.
NTI'S biosecurity program partnered with ACDC to sponsor the second event in a series of workshops to advance ACDC's initiative to stregthen biosecurity and biosafety.
Sign up for our newsletter to get the latest on nuclear and biological threats.
Sign up for regular updates on innovative, real-world solutions to existential threats.
{ location = 'https://www.nti.org/get-updates/' }, 300);">Get Updates